论文部分内容阅读
目的 探讨胃癌术中腹腔内温热灌洗化疗 (intraperitonealhyperthermicperfusionchemotherapy,IHPC)加腹膜内注射化疗对胃癌术后腹膜转移和生存期的影响。 方法 将胃癌患者 5 8例随机分成A、B两组 ,A组单行手术治疗 ,B组行手术加IHPC及丝裂霉素 活性碳混悬液 (MMC CH)腹膜内注射 ,观察两组病人术后的并发症及 1、3年生存率。结果 A组 1年生存率为 86 6 7% ,B组为85 71% ,P >0 0 5。A组 3年生存率为 36 6 7% ,B组为 5 7 14% ,P <0 0 1。两组病人术后 3年和 1年生存率之间的差异有显著性 ,但两组病人术后并发症之间的差异无显著性。结论 胃癌手术中辅以IHPC及腹膜内注射化疗对于防治胃癌的腹膜淋巴转移、腹膜复发 ,提高生存率有重要价值
Objective To investigate the effect of intraperitoneal hyperthermic perfusion chemotherapy (IHPC) and intraperitoneal chemotherapy on the peritoneal metastasis and survival of patients with gastric cancer after operation. Methods Fifty-eight patients with gastric cancer were randomly divided into two groups: group A and group B, and group B received intraperitoneal injection of IHPC and MMC CH. After the complications and 1, 3-year survival rate. Results The 1-year survival rate was 86.67% in group A, 85.71% in group B, P> 0.05. The 3-year survival rate in group A was 36 6 7%, in group B 5 7 14%, P 0 01. The difference between 3-year and 1-year survival rates of the two groups of patients was significant, but there was no significant difference between the two groups in postoperative complications. Conclusion Intraperitoneal chemotherapy combined with IHPC in gastric cancer surgery is of great value in preventing and treating peritoneal lymphatic metastasis, retroperitoneal recurrence and increasing survival rate of gastric cancer